(Q33971524)

English

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

Ying-Jun Chang

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cui-Lian Weng

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Li-Xia Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Yun-Tao Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

26 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

427-437

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Systematic review and meta-analysis methodology

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Aggregate data meta-analysis with time-to-event outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Advanced methods in meta-analysis: multivariate approach and meta-regression.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

High-dose cyclophosphamide for graft-versus-host disease prevention

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1299-8

21 January 2018

Identifiers

10.1007/S00277-011-1299-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33971524&oldid=1644970174"